Advances in genomics and molecular biology are transforming how researchers study disease, gene regulation, and cellular function across healthcare and life science applications. In our latest Genomics Editorial eBook, we’ve compiled expert insights, emerging research, and application-focused articles that explore the technologies and discoveries shaping modern genomics workflows.
What’s inside the Genomics eBook?
This eBook explores the growing role of sequencing technologies, gene editing tools, epigenetics, and molecular analysis in advancing biological research and precision medicine. From single-cell RNA sequencing and PCR purification to CRISPR research and oligonucleotide delivery, the collection highlights how genomics technologies are supporting a stronger understanding of gene expression, cellular behavior, and disease mechanisms.
The eBook also examines emerging research on brain development, epigenetic regulation, and antibiotic persistence, as well as practical workflow considerations, such as liquid-handling solutions for next-generation sequencing laboratories. Advances in genome engineering are also featured, including research into CRISPR enzymes that respond to human DNA methylation.
Whether you work in genomics research, molecular biology, biotechnology, or clinical science, this eBook provides valuable insight into the technologies and discoveries shaping the future of genomics.
Highlights from this eBook include:
- Understanding plate, droplet, and microwell approaches in single-cell RNA sequencing
- New theories surrounding brain development
- How diet influences gene expression through epigenetic mechanisms
- Streamlining NGS workflows with liquid handling solutions
- Research into lethal mutations caused by transposable elements
- CRISPR enzymes that respond to human DNA methylation
- Getting started with PCR purification
- Strategies for oligonucleotide delivery across the blood-brain barrier
About INTEGRA Biosciences
INTEGRA Biosciences (www.integra-biosciences.com) is a leading provider of high-quality laboratory tools and consumables for liquid handling.
The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. INTEGRA's portfolio also encompasses next-generation sequencing (NGS) solutions, with automated workflows and magnetic bead-based reagents for reliable NGS sample preparation.
INTEGRA's engineering and production teams in Zizers, Switzerland and Hudson, NH, USA, strive to develop and manufacture instruments and consumables of outstanding quality. Today, INTEGRA's innovative laboratory products are widely used all around the world where they help scientists accelerate scientific discovery.
In recent years, they have focused on developing a new and technologically advanced range of lab devices that are simple to use and meet the ergonomic needs of their customers. Today, they are proud to offer the widest range of electronic pipettes on the market, covering everything from single-channel pipettes to 384-channel bench-top instruments.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.